Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Oct 21, 2024

BUY
$3.28 - $4.81 $458,216 - $671,957
139,700 New
139,700 $483,000
Q1 2023

May 03, 2023

BUY
$3.28 - $4.81 $458,216 - $671,957
139,700 New
139,700 $483,000
Q2 2022

Aug 09, 2022

SELL
$2.42 - $4.05 $136,246 - $228,015
-56,300 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$3.45 - $5.83 $194,235 - $328,229
56,300 New
56,300 $221,000
Q4 2021

Feb 10, 2022

SELL
$4.89 - $7.59 $457,214 - $709,665
-93,500 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$5.18 - $7.41 $484,330 - $692,835
93,500 New
93,500 $674,000
Q1 2021

May 17, 2021

SELL
$4.03 - $7.25 $70,928 - $127,600
-17,600 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$2.78 - $4.5 $48,928 - $79,200
17,600 New
17,600 $67,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.